video
video
#3
Join us for the 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗙𝗼𝗿𝘂𝗺, an insightful virtual session focused on advancing prostate cancer management through evidence-based hormonal therapy approaches and clinical decision-making.
The session, 𝗟𝗲𝘂𝗽𝗿𝗼𝗹𝗶𝗱𝗲 𝗔𝗰𝗲𝘁𝗮𝘁𝗲 𝗮𝘀 𝘁𝗵𝗲 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗗𝗧: 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗟𝗛𝗥𝗛 𝗔𝗴𝗼𝗻𝗶𝘀𝘁 & 𝗔𝗻𝘁𝗮𝗴𝗼𝗻𝗶𝘀𝘁 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀, will bring together healthcare experts to discuss evolving treatment strategies in androgen deprivation therapy (ADT) and their impact on patient outcomes.
Gain valuable insights into therapeutic differentiation, clinical considerations, treatment sequencing, an
Read more (full body)
Join us for the 𝗡𝗮𝘁𝗶𝗼𝗻𝗮𝗹 𝗣𝗿𝗼𝘀𝘁𝗮𝘁𝗲 𝗖𝗮𝗻𝗰𝗲𝗿 𝗙𝗼𝗿𝘂𝗺, an insightful virtual session focused on advancing prostate cancer management through evidence-based hormonal therapy approaches and clinical decision-making.
The session, 𝗟𝗲𝘂𝗽𝗿𝗼𝗹𝗶𝗱𝗲 𝗔𝗰𝗲𝘁𝗮𝘁𝗲 𝗮𝘀 𝘁𝗵𝗲 𝗙𝗼𝘂𝗻𝗱𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗔𝗗𝗧: 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗗𝗶𝗳𝗳𝗲𝗿𝗲𝗻𝘁𝗶𝗮𝘁𝗶𝗼𝗻 𝗯𝗲𝘁𝘄𝗲𝗲𝗻 𝗟𝗛𝗥𝗛 𝗔𝗴𝗼𝗻𝗶𝘀𝘁 & 𝗔𝗻𝘁𝗮𝗴𝗼𝗻𝗶𝘀𝘁 𝗔𝗽𝗽𝗿𝗼𝗮𝗰𝗵𝗲𝘀, will bring together healthcare experts to discuss evolving treatment strategies in androgen deprivation therapy (ADT) and their impact on patient outcomes.
Gain valuable insights into therapeutic differentiation, clinical considerations, treatment sequencing, and practical perspectives that can support optimized prostate cancer care in India.
𝗗𝗮𝘁𝗲: 20th May 2026
𝗧𝗶𝗺𝗲: 8:00 PM – 9:00 PM
𝗔𝗻 𝗜𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲 𝗕𝘆: Voice of Healthcare
𝗦𝘂𝗽𝗽𝗼𝗿𝘁𝗲𝗱 𝗕𝘆: BSV & Mankind Pharma
Be part of this important discussion advancing clinical excellence and innovation in prostate cancer management.
#ProstateCancer #NationalProstateCancerForum #Oncology #CancerCare #HealthcareIndia #ClinicalExcellence #VOH #BSV #MankindPharma #MedicalEducation